Figure 1.

Patients with persistent viral replication (≥10⁶ copies/mL) after sotrovimab administration. A, Prolonged viral shedding by day 21 after the first positive SARS-CoV-2 PCR test according to immunocompetence. B, Prolonged viral shedding by day 21 after sotrovimab administration in immunocompetent patients and patients with immunodeficiency. Numbers at risk are patients with a viral load ≥10⁶ copies/mL; censored are patients lost to follow-up (1 patient was first lost to follow-up on day 28 and was included in numbers at risk). Abbreviations: PCR, polymerase chain reaction; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.